ABIVAX Socit Company Top Executives
| AAVXF Stock | USD 12.36 0.00 0.00% |
ABIVAX Socit employes about 24 people. The company is managed by 26 executives with a total tenure of roughly 11 years, averaging almost 0.0 years of service per executive having 0.92 employees per reported executive. Examination of ABIVAX Socit management performance can provide insight into the company performance. Note, employee analysis is becoming a valuable factor that investors use to determine the amount of risk that may be associated with ABIVAX Socit Anonyme future performance.
| Hartmut Ehrlich CEO CEO |
| Philippe Pouletty Chairman Chairman of the Board |
| Bernard Fanget President Vice President - Process Development and Manufacturing |
ABIVAX |
ABIVAX Socit Management Team Effectiveness
The company has return on total asset (ROA) of (0.4368) % which means that it has lost $0.4368 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (12.8647) %, meaning that it generated substantial loss on money invested by shareholders. ABIVAX Socit's management efficiency ratios could be used to measure how well ABIVAX Socit manages its routine affairs as well as how well it operates its assets and liabilities.ABIVAX Socit Workforce Comparison
ABIVAX Socit Anonyme is number one stock in number of employees category among related companies. The total workforce of Biotechnology industry is presently estimated at about 302,955. ABIVAX Socit adds roughly 24.0 in number of employees claiming only tiny portion of stocks in Biotechnology industry.
ABIVAX Socit Anonyme Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. ABIVAX Socit Anonyme Price Series Summation is a cross summation of ABIVAX Socit price series and its benchmark/peer..
ABIVAX Socit Notable Stakeholders
An ABIVAX Socit stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as ABIVAX Socit often face trade-offs trying to please all of them. ABIVAX Socit's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting ABIVAX Socit's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Hartmut Ehrlich | CEO | Profile | |
| Philippe Pouletty | Chairman of the Board | Profile | |
| Bernard Fanget | Vice President - Process Development and Manufacturing | Profile | |
| Didier Scherrer | Vice President - Research & Development Small Molecules | Profile | |
| Vincent Serra | Vice President - Research & Development Viral Vaccines | Profile | |
| Alexandra Pearce | Vice President and Head of Regulatory Affairs | Profile | |
| Karl Birthistle | Vice President Chief Medical Officer and Vice President Clinical & Regulatory Affairs | Profile | |
| Pierre Courteille | Vice President - Business Development, Chief Commercial Officer | Profile | |
| Didier Blondel | CFO, Board Secretary | Profile | |
| Miguel Sieler | Director | Profile | |
| Christian Pierret | Director | Profile | |
| JeanJacques Bertrand | Director | Profile | |
| Jerome Gallot | Director | Profile | |
| Claude Bertrand | Director | Profile | |
| Joy Amundson | Director | Profile | |
| Antoine Pau | Director | Profile | |
| JeanPaul Prieels | Director | Profile | |
| Alain Chevallier | Advisor | Profile | |
| Philippe MD | Founder Director | Profile | |
| Prof Ehrlich | Chief Officer | Profile | |
| Paul Gineste | VP Operations | Profile | |
| Pierre MBA | Chief Devel | Profile | |
| Regina Jehle | VP Communications | Profile | |
| JeanMarc Steens | Chief Medical Officer | Profile | |
| Anne Pascard | HR Mang | Profile | |
| Raquel Lizarraga | Investor Mang | Profile |
About ABIVAX Socit Management Performance
The success or failure of an entity such as ABIVAX Socit Anonyme often depends on how effective the management is. ABIVAX Socit management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of ABIVAX management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the ABIVAX management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
ABIVAX Socit Anonyme discovers and optimizes drugs for the treatment of inflammatory diseases, infectious diseases, and cancer in France. The company was incorporated in 2013 and is headquartered in Paris, France. Abivax Sa is traded on OTC Exchange in the United States.
The data published in ABIVAX Socit's official financial statements usually reflect ABIVAX Socit's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of ABIVAX Socit Anonyme. For example, before you start analyzing numbers published by ABIVAX accountants, it's critical to develop an understanding of what ABIVAX Socit's liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of ABIVAX Socit's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, ABIVAX Socit's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in ABIVAX Socit's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of ABIVAX Socit Anonyme. Please utilize our Beneish M Score to check the likelihood of ABIVAX Socit's management manipulating its earnings.
ABIVAX Socit Workforce Analysis
Traditionally, organizations such as ABIVAX Socit use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare ABIVAX Socit within its industry.ABIVAX Socit Manpower Efficiency
Return on ABIVAX Socit Manpower
| Revenue Per Employee | 1.5K | |
| Revenue Per Executive | 1.4K | |
| Net Loss Per Employee | 1.7M | |
| Net Loss Per Executive | 1.6M |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ABIVAX Socit Anonyme. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in national income and product accounts. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Complementary Tools for ABIVAX Pink Sheet analysis
When running ABIVAX Socit's price analysis, check to measure ABIVAX Socit's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ABIVAX Socit is operating at the current time. Most of ABIVAX Socit's value examination focuses on studying past and present price action to predict the probability of ABIVAX Socit's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ABIVAX Socit's price. Additionally, you may evaluate how the addition of ABIVAX Socit to your portfolios can decrease your overall portfolio volatility.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |